Navigation Links
International Isotopes Inc. Names James Mayer as Chief Operating Officer
Date:1/14/2008

IDAHO FALLS, Idaho, Jan. 14 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) is pleased to announce the appointment of James Mayer as Chief Operating Officer (COO).

James Mayer joined International Isotopes as Chief Operating Officer on January 11, 2008. Mr. Mayer received his Bachelor of Science in Nuclear Engineering from Texas A & M University and a Masters of Business Administration from the University of Nebraska at Lincoln. He has over 25 years of management experience in the U.S. Navy as well as civilian corporations and he has previously served as Facility Manager, Senior Project Engineer, and Production Manager at a Fortune 500 corporation.

Steve T. Laflin, International Isotopes Inc. President and Chief Executive Officer said, "The Company has not previously had a COO position. However, our rapidly growing manufacturing operations and increasing corporate demands created by additional business opportunities for the Company dictate the need for a dedicated COO. Mr. Mayer has in-depth familiarity with the nuclear industry as well as the commercial sector. He brings with him solid business, management, and operational skills and broad-based experience in manufacturing. He is an outstanding fit to our team and I am certain he will become a valuable asset to the Company as we strive to improve our production efficiencies, reduce operating costs, and incorporate new product lines into the Idaho operations."

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

For more information, visit our website: http://www.intisoid.com

International Isotopes Inc. Safe Harbor Statement

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change. Actual results may differ materially from the forward-looking statements. Many factors could cause actual results to differ materially from the forward-looking statements. Readers are directed to read the risk factors detailed from time to time in our filings with the Securities and Exchange Commission, including our annual report on Form 10-KSB for the year ending December 31, 2006. The Company does not intend to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For More Information, Contact:

Steve Laflin, President and CEO

(208) 524-5300


'/>"/>
SOURCE International Isotopes Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International brain aging expert challenges the existence of Alzheimers as a disease
2. EHE International Supports the American Liver Foundations Efforts at Raising Awareness for Hepatitis
3. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
4. International Sports Sciences Associations Ten Best Resolutions for Better Health in 2008
5. Joint Commission International Achieves Accreditation from ISQua
6. International Development Expert to Lead the Pan American Health and Education Foundation
7. Natural Nutrition Launches Long Life Cocktail with International Television Ad Campaign
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. NEWSWEEK: International Editions: Highlights and Exclusives, Dec. 31, 2007- Jan. 7, 2008
10. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
11. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: